about
Robust free-breathing SASHA T1 mapping with high-contrast image registration.Clinical Utility and Future Applications of PET/CT and PET/CMR in Cardiology.Current Understanding of the Pathophysiology of Myocardial Fibrosis and Its Quantitative Assessment in Heart Failure.T1 mapping in cardiac MRI.Isosorbide Dinitrate, With or Without Hydralazine, Does Not Reduce Wave Reflections, Left Ventricular Hypertrophy, or Myocardial Fibrosis in Patients With Heart Failure With Preserved Ejection Fraction.Towards accurate and precise T 1 and extracellular volume mapping in the myocardium: a guide to current pitfalls and their solutions.Deciphering cardiac involvement in systemic inflammatory diseases: noninvasive tissue characterisation using cardiac magnetic resonance is key to improved patients' care.Cardiac MRI: a Translational Imaging Tool for Characterizing Anthracycline-Induced Myocardial Remodeling.When should we use contrast material in cardiac MRI?Motion-robust cardiac B1+ mapping at 3T using interleaved bloch-siegert shifts.Myocardial Architecture, Mechanics, and Fibrosis in Congenital Heart Disease.Recent Advances in Cardiovascular Magnetic Resonance: Techniques and Applications.Cardiovascular magnetic resonance imaging to assess myocardial fibrosis in valvular heart disease.The influence of microvascular injury on native T1 and T2* relaxation values after acute myocardial infarction: implications for non-contrast-enhanced infarct assessment.Early gadolinium enhancement in hypertrophic cardiomyopathy: a potential premature marker of myocardial damage.Pulmonary hypertension: diagnosis, imaging techniques, and novel therapies.Tissue segmentation: a crucial tool for quantitative MRI and visualization of anatomical structures.Inflammation and Fibrosis in HIV: Getting to the Heart of the Matter.The prognostic value of T1 mapping and late gadolinium enhancement cardiovascular magnetic resonance imaging in patients with light chain amyloidosis.Increased myocardial extracellular volume assessed by cardiovascular magnetic resonance T1 mapping and its determinants in type 2 diabetes mellitus patients with normal myocardial systolic strain.SASHA versus ShMOLLI: a comparison of T1 mapping methods in health and dilated cardiomyopathy at 3 T.Extracellular volume quantification by cardiac magnetic resonance imaging without hematocrit sampling : Ready for prime time?Early detection of myocardial involvement by T1 mapping of cardiac MRI in idiopathic inflammatory myopathy.Quantitative Molecular Imaging with a Single Gd-Based Contrast Agent Reveals Specific Tumor Binding and Retention in Vivo.Black-blood native T1 mapping: Blood signal suppression for reduced partial voluming in the myocardium.Cardiac magnetic resonance imaging of myocardial mass and fibrosis in primary aldosteronism.Characterizing Cardiac Involvement in Chronic Kidney Disease Using CMR-a Systematic Review.Cardiac Magnetic Resonance to Evaluate Percutaneous Pulmonary Valve Implantation in Children and Young Adults.Noninvasive hematocrit assessment for cardiovascular magnetic resonance extracellular volume quantification using a point-of-care device and synthetic derivation.Impact of Systemic Volume Status on Cardiac Magnetic Resonance T1 Mapping.Assessment of myocardial fibrosis using T1-mapping and extracellular volume measurement on cardiac magnetic resonance imaging for the diagnosis of radiation-induced cardiomyopathyMyocardial tissue characterization and strain analysis in healthy pregnant women using cardiovascular magnetic resonance native T1 mapping and feature tracking technique
P2860
Q27303536-E37B8C73-0CCD-4A90-952B-3CD8F2DE0C5CQ28073135-24CD7117-59E3-4E90-8D7A-D7055DE88F9EQ33595504-AC481156-4FEC-4AF8-8CD0-1DC769C8A3ADQ33844044-F943D147-6DA1-4CE4-AE60-A6604E67A237Q38380558-F8F21ECD-A508-4BDB-BEFA-9213DABABADBQ38671622-83BFE408-6836-487A-B633-2328F0545639Q38830086-F61FB3AD-290A-40B1-9DAA-0CFAE498F396Q38862688-62913F25-9767-4613-B9A8-58ADC595FBA8Q39290073-14C4AE44-E5AF-41F5-B7BC-9B9833DCE8AFQ39296780-C548F952-22EB-469E-B6D1-93CA9E8B36E1Q39355931-CB59016B-2FB9-4737-8F83-5E2BD2CF63A3Q39370604-5B9705FB-E5DC-4A88-A4FE-8183FE81F32EQ39392998-FC8EF501-FFC4-4ED3-9B26-8748D6CDE6BBQ40077869-97773CA6-8C42-49FB-8F6A-4EAF657846D9Q40629942-9FF06500-CB11-4AA8-9AFE-3882D0B30208Q41598705-4C35D565-80F0-4CF1-AE4A-3256C1C1C11DQ43893279-BB6EFB20-4EEF-495C-86D5-F95BA222B7BAQ46016322-35FBEA33-293D-4963-9947-464435056E58Q47098908-3CA0EA9C-CA86-4AC7-A41F-E7748B4C30CBQ47285651-B479EA97-433F-4332-A44E-47DB373FAFFEQ47352899-19E97595-4C1F-4E2F-B05D-D72B3DA67819Q47619369-08E0761D-9EAE-4BDF-BB31-9C598A659001Q47867796-178FCEF3-EDC0-4166-AADC-2B258B69F1A7Q48178834-43941E95-1021-4CAC-BFAC-1D72605E0FB5Q48794015-F2ACE22D-E2E7-4327-86E5-0B9933C4EDBFQ50027498-74624100-9259-44E5-A8D5-1028CD6B3ADEQ52678001-C148E6CE-3703-4C4C-B3F4-4A3E75F6ED1EQ55024883-61A05A31-C239-4FB6-BBB1-DD7865848321Q55419964-33CCADF5-5CE0-4763-BCE6-D25AFAF2CB86Q55494001-F1604E47-B536-4676-8C92-2ECE521A12D1Q57143060-077920FF-5E1A-4A92-A427-02BA12469B0EQ58803160-96C07E9C-0BBB-494F-8BD0-972211AF2816
P2860
description
2016 nî lūn-bûn
@nan
2016 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
T1 Mapping: Basic Techniques and Clinical Applications.
@ast
T1 Mapping: Basic Techniques and Clinical Applications.
@en
type
label
T1 Mapping: Basic Techniques and Clinical Applications.
@ast
T1 Mapping: Basic Techniques and Clinical Applications.
@en
prefLabel
T1 Mapping: Basic Techniques and Clinical Applications.
@ast
T1 Mapping: Basic Techniques and Clinical Applications.
@en
P1476
T1 Mapping: Basic Techniques and Clinical Applications.
@en
P2093
Andrew J Taylor
Rohan Dharmakumar
P356
10.1016/J.JCMG.2015.11.005
P577
2016-01-01T00:00:00Z